All diseases

Disease Atlas / Disease detail

Eye Cancer

This is educational material designed to help you understand the general framework of types, symptoms, diagnosis, and treatment of eye cancer.

ocular cancer · cancer of eye · cancer of eyeball of camera-type eye · cancer of the eye · eye cancer · eye neoplasm · eye neoplasm, malignant · eyeball of camera-type eye cancer · malignant eye neoplasm · malignant eye tumor · malignant eye tumour · malignant eyeball of camera-type eye neoplasm · malignant neoplasm of eye · malignant neoplasm of eyeball of camera-type eye · malignant neoplasm of the eye · malignant ocular neoplasm · malignant ocular tumor · malignant ocular tumour · malignant tumor of eye · malignant tumor of the eye · malignant tumour of eye · malignant tumour of the eye · neoplasm of eye · ocular tumor · ocular tumour

MONDO:0002236Public QA completeSource-bound · 5

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · d846c76773ff

Disease Category
Eye cancer is a general term for malignant tumors that occur in the outer structures of the eye or inside the eyeball; intraocular cancers may include melanoma and lymphoma in adults, and retinoblastoma in children.
Core mechanism
Causes and related factors vary depending on the tumor type and age, and in some cases, genetic predisposition or genetic changes in cells may be involved.
Main causes · Related factors
The core mechanism of cancer is that abnormal cells proliferate without regulation and can invade surrounding tissues or spread to other parts.
Representative patterns
Representative clinical manifestations can appear as decreased vision, changes in visual field, changes in the shape or color of the eye, or lumps around the eyelid or eyeball, and vary depending on the location and type of the tumor.
Individual differences
Risk factors and prognosis vary for each individual depending on age, tumor site and cell type, genetic background, tumor size, and presence of metastasis.
Diagnosis
In the early stages, symptoms may not be distinct, but as it progresses, visual abnormalities, decreased vision, pain, redness, or protrusion of the eye may appear, and the prognosis varies by tumor type.
Management
Diagnosis is performed by identifying the type and extent of the tumor through a combination of imaging tests, biopsy if necessary, and staging, based on medical history and ophthalmic examination.
Treatment/Research Status
Since similar changes in vision or ocular symptoms can occur in other diseases, test results must be interpreted along with the type, location, and stage of the tumor and are not confirmed by a single test alone.
Evidence Reading
Management is planned through the collaboration of ophthalmologists and oncologists, considering the tumor type, stage of progression, possibility of vision preservation, and presence of metastasis.
Key Precautions
Treatments may include surgery, radiotherapy, cryotherapy, thermotherapy, or laser therapy, and the choice depends on the tumor type and stage of progression.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a Glance

Eye cancer is a general term for malignant tumors that occur in the outer structures of the eye or inside the eyeball; intraocular cancers may include melanoma and lymphoma in adults, and retinoblastoma in children.

Representative clinical manifestations can appear as decreased vision, changes in visual field, changes in the shape or color of the eye, or lumps around the eyelid or eyeball, and vary depending on the location and type of the tumor.

How the Disease Works

Causes and related factors vary depending on the tumor type and age, and in some cases, genetic predisposition or genetic changes in cells may be involved.

The core mechanism of cancer is that abnormal cells proliferate without regulation and can invade surrounding tissues or spread to other parts.

Patterns Vary by Person

Risk factors and prognosis vary for each individual depending on age, tumor site and cell type, genetic background, tumor size, and presence of metastasis.

Broad framework of diagnosis and management

In the early stages, symptoms may not be distinct, but as it progresses, visual abnormalities, decreased vision, pain, redness, or protrusion of the eye may appear, and the prognosis varies by tumor type.

Diagnosis is performed by identifying the type and extent of the tumor through a combination of imaging tests, biopsy if necessary, and staging, based on medical history and ophthalmic examination.

Current stage of treatment

Since similar changes in vision or ocular symptoms can occur in other diseases, test results must be interpreted along with the type, location, and stage of the tumor and are not confirmed by a single test alone.

Management is planned through the collaboration of ophthalmologists and oncologists, considering the tumor type, stage of progression, possibility of vision preservation, and presence of metastasis.

Treatments may include surgery, radiotherapy, cryotherapy, thermotherapy, or laser therapy, and the choice depends on the tumor type and stage of progression.

How to read clinical trials

There are registration records for an observational study of vitreoretinal lymphoma associated with ocular cancer, but study registration alone cannot determine treatment efficacy or whether it is standard care, nor does it imply that study results have been confirmed.

Points to verify in clinical encounters

In clinical practice, the onset and changes of symptoms, involvement of one or both eyes, changes in vision/visual field, past cancer and family history, performed examinations and treatments, and vision preservation goals must be confirmed; if sudden worsening or severe pain occurs, medical staff or the local emergency medical system must be contacted immediately.

Medical Guide

This material is for educational purposes and does not replace individual diagnosis or treatment. Please consult with medical professionals for judgments regarding symptoms or test results and for treatment decisions.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.